Immunotherapy of solid tumors. I. Preliminary studies with nitrogen mustard for nonspecific immunopotentiation in human caner.
D000230:Adenocarcinoma / Q000188:drug therapy; D000287:Administration, Topical; D000912:Antibodies, Neoplasm; D000917:Antibody Formation; D001943:Breast Neoplasms / Q000188:drug therapy; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed; D007167:Immunotherapy; D008297:Male; D008545:Melanoma / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000276:immunology; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000188:drug therapy; D012075:Remission, Spontaneous; D012878:Skin Neoplasms / Q000188:drug therapy; D012882:Skin Tests
D000912:Antibodies, Neoplasm; D009588:Nitrogen Mustard Compounds